Modèle gratuit

    Medical Device Approval: FDA submission process with clinical trials, documentation, regulatory review, and market clearance phases

    Navigating FDA medical device approval requires meticulous planning across multiple complex phases. From preclinical research through clinical trials, regulatory documentation, FDA review processes, and final market clearance, each step demands careful coordination, timeline management, and compliance with strict regulatory requirements for successful approval.

    Ce que contient ce modèle

    This template comes with 71 ready-made tasks organized into 21 phases, covering roughly 295 weeks of work. Start dates, durations, and dependencies are already set up — use it as-is or adjust anything to fit your project.

    Medical Device Approval: FDA submission process with clinical trials, documentation, regulatory review, and market clearance phases
    #Nom de la tâcheDurée
    1
    Preclinical Research and Device Development
    182j
    1.1
    Market Research and Competitive Analysis
    31j
    1.2
    Device Design and Engineering
    61j
    1.3
    Prototype Development and Testing
    31j
    1.4
    Biocompatibility Testing
    31j
    1.5
    Risk Management Documentation (ISO 14971)
    28j
    2
    Quality Management System Establishment
    90j
    2.1
    ISO 13485 Quality System Implementation
    46j
    2.2
    Design Controls Documentation
    28j
    2.3
    Manufacturing Process Development
    16j
    3
    Pre-Submission Activities
    92j
    3.1
    FDA Pre-Submission Meeting Request
    15j
    3.2
    Pre-Submission Package Preparation
    31j
    3.3
    FDA Pre-Submission Meeting
    15j
    3.4
    Protocol Refinement Based on FDA Feedback
    31j
    4
    Clinical Trial Phase I Planning
    92j
    4.1
    Clinical Protocol Development
    31j
    4.2
    Investigational Device Exemption (IDE) Preparation
    31j
    4.3
    Clinical Site Selection and Contracting
    30j
    5
    Clinical Trial Phase I Execution
    181j
    5.1
    IDE Submission to FDA
    15j
    5.2
    FDA IDE Review and Approval
    46j
    5.3
    IRB Approvals at Clinical Sites
    30j
    5.4
    Patient Recruitment and Enrollment
    31j
    5.5
    Phase I Clinical Data Collection
    46j
    5.6
    Phase I Data Analysis and Reporting
    13j
    6
    Clinical Trial Phase II Planning
    89j
    6.1
    Phase II Protocol Development
    28j
    6.2
    IDE Amendment Preparation
    31j
    6.3
    Expanded Clinical Site Network Setup
    30j
    7
    Clinical Trial Phase II Execution
    184j
    7.1
    IDE Amendment Submission and Approval
    31j
    7.2
    Phase II Patient Recruitment
    61j
    7.3
    Phase II Clinical Data Collection
    61j
    7.4
    Phase II Data Analysis and Statistical Review
    31j
    8
    Clinical Trial Phase III Planning
    92j
    8.1
    Pivotal Study Protocol Development
    31j
    8.2
    Biostatistical Analysis Plan Finalization
    30j
    8.3
    Multi-Center Clinical Site Preparation
    31j
    9
    Clinical Trial Phase III Execution
    244j
    9.1
    Pivotal Study IDE Submission
    15j
    9.2
    FDA Pivotal Study Approval
    45j
    9.3
    Large-Scale Patient Enrollment
    61j
    9.4
    Pivotal Study Data Collection
    61j
    9.5
    Final Clinical Data Analysis
    31j
    9.6
    Clinical Study Report Preparation
    31j
    10
    Manufacturing and Quality Documentation
    153j
    10.1
    Manufacturing Scale-Up and Validation
    61j
    10.2
    Device Master Record Compilation
    31j
    10.3
    Design History File Completion
    30j
    10.4
    Quality Assurance Final Review
    31j
    11
    Regulatory Submission Preparation
    122j
    11.1
    PMA Application Document Assembly
    46j
    11.2
    Regulatory Affairs Team Final Review
    30j
    11.3
    Legal and Compliance Review
    31j
    11.4
    Executive Management Approval
    15j
    12
    FDA Premarket Approval (PMA) Submission
    31j
    12.1
    PMA Submission Package Finalization
    15j
    12.2
    Electronic Submission to FDA
    16j
    13
    FDA Administrative Review
    46j
    13.1
    FDA Filing Review and Acceptance
    31j
    13.2
    User Fee Payment Processing
    15j
    14
    FDA Scientific Review
    181j
    14.1
    FDA Scientific and Clinical Review
    89j
    14.2
    FDA Manufacturing and Quality Review
    61j
    14.3
    FDA Risk-Benefit Assessment
    31j
    15
    FDA Advisory Panel Process
    61j
    15.1
    Advisory Panel Meeting Preparation
    31j
    15.2
    Advisory Panel Presentation
    15j
    15.3
    Post-Panel Response and Follow-up
    15j
    16
    FDA Facility Inspection
    46j
    16.1
    Pre-Inspection Preparation
    16j
    16.2
    FDA Facility Inspection Execution
    15j
    16.3
    Inspection Response and Remediation
    15j
    17
    Final FDA Review and Decision
    62j
    17.1
    FDA Final Determination Process
    46j
    17.2
    PMA Approval Letter Issuance
    16j
    18
    Post-Market Requirements Preparation
    59j
    18.1
    Post-Market Study Protocol Development
    31j
    18.2
    Labeling Finalization and Approval
    28j
    19
    Commercial Launch Preparation
    89j
    19.1
    Manufacturing Scale-Up for Commercial Production
    43j
    19.2
    Supply Chain and Distribution Setup
    31j
    19.3
    Sales and Marketing Team Training
    15j
    20
    Market Launch and Commercialization
    92j
    20.1
    Product Launch Campaign Execution
    31j
    20.2
    Healthcare Provider Training Programs
    30j
    20.3
    Post-Market Surveillance System Activation
    31j
    21
    Post-Market Compliance and Monitoring
    273j
    21.1
    Adverse Event Reporting System Implementation
    31j
    21.2
    Post-Market Study Execution
    181j
    21.3
    Annual PMA Report Preparation
    61j
    71 tâches·21 phases·~295 semaines
    Prêt à personnaliser

    Understanding FDA Medical Device Approval Process

    The FDA medical device approval process is one of the most complex and regulated pathways in product development. This comprehensive process ensures that medical devices meet strict safety and efficacy standards before reaching patients and healthcare providers. The journey from concept to market clearance involves multiple interconnected phases that require careful coordination, extensive documentation, and adherence to rigorous regulatory requirements.

    Key Phases of Medical Device Approval

    The FDA approval process typically involves several critical phases that must be executed in sequence, with each phase building upon the previous one's success:

    • Preclinical Research and Development. This initial phase involves device design, prototype development, bench testing, and animal studies to demonstrate basic safety and functionality before human trials can begin.
    • Clinical Trial Phases. Depending on the device classification, clinical trials may include Phase I (safety and feasibility), Phase II (effectiveness evaluation), and Phase III (large-scale efficacy studies) to gather comprehensive data on device performance.
    • Regulatory Documentation Preparation. This involves compiling extensive documentation including clinical study reports, manufacturing information, risk analysis, labeling, and quality system documentation required for FDA submission.
    • FDA Submission Process. Submitting the appropriate application (510(k), PMA, or De Novo) with all required documentation, paying applicable fees, and responding to any initial FDA feedback or requests for additional information.
    • Regulatory Review Period. The FDA conducts a thorough review of all submitted materials, which may include facility inspections, advisory panel meetings, and multiple rounds of questions and responses between the manufacturer and FDA.
    • Market Clearance and Launch. Upon FDA approval or clearance, final preparations for market launch including manufacturing scale-up, distribution planning, and post-market surveillance setup.

    Critical Success Factors in Medical Device Approval

    Successfully navigating the FDA approval process requires meticulous project management and coordination across multiple specialized teams. Key factors include maintaining regulatory compliance throughout development, ensuring robust clinical trial design and execution, preparing comprehensive and accurate documentation, and maintaining open communication with FDA reviewers. Timeline management is crucial as delays in any phase can cascade through the entire approval process, potentially adding months or years to market entry.

    Why Use Gantt Charts for Medical Device Approval Planning?

    The complexity of medical device approval makes it an ideal candidate for visual project management using Gantt charts. With Instagantt, medical device companies can effectively plan and track the intricate dependencies between clinical trials, regulatory milestones, documentation deadlines, and review periods. The visual timeline helps identify potential bottlenecks, manage resource allocation across different phases, and ensure all team members understand critical deadlines and dependencies.

    Gantt charts provide essential visibility into the approval process, allowing project managers to monitor progress across multiple concurrent activities, track regulatory submission deadlines, and coordinate between clinical teams, regulatory affairs specialists, quality assurance personnel, and manufacturing teams. This comprehensive oversight is essential for maintaining project momentum and ensuring successful FDA approval within projected timelines.

    Start planning your medical device approval process with the structure and visibility needed for regulatory success.

    Prêt à l'emploi

    Commencez à travailler immédiatement avec ce modèle prédéfini. Aucune configuration requise.

    Conçu pour les équipes

    Partagez avec votre équipe, attribuez des tâches et collaborez en temps réel.

    Entièrement personnalisable

    Adaptez chaque tâche, chronologie et dépendance à votre flux de travail.

    Foire aux questions

    Que contient le modèle Medical Device Approval: FDA submission process with clinical trials, documentation, regulatory review, and market clearance phases ?

    Le modèle comprend 92 tâches prêtes à l'emploi organisées en 21 phases, avec des dates, des durées et des dépendances modifiables, de sorte que le planning se mette à jour automatiquement en cas de modification.

    Ce modèle de diagramme de Gantt est-il gratuit ?

    Oui. Vous pouvez ouvrir le modèle, explorer le plan complet et commencer à le personnaliser avec un compte Instagantt gratuit — l'offre gratuite couvre jusqu'à 3 projets sans limite de durée.

    Puis-je personnaliser les tâches, les dates et les phases ?

    Oui, tout est modifiable. Renommez ou supprimez des tâches, faites glisser les barres pour modifier les dates, ajoutez des dépendances et des jalons, attribuez des responsables et ajoutez de nouvelles phases. Les tâches dépendantes sont automatiquement reprogrammées lorsque vous déplacez un élément en amont.

    Puis-je partager le plan avec des personnes qui n'ont pas Instagantt ?

    Oui. Chaque projet peut générer un lien d'instantané public en lecture seule que les parties prenantes et les clients peuvent ouvrir dans un navigateur sans compte, ainsi que des exports PDF et image pour les rapports et les présentations.

    Commencez la planification avec ce modèle

    Utilisez ce modèle de diagramme de Gantt pour lancer votre projet en quelques minutes. Personnalisez-le pour répondre précisément à vos besoins.

    Intégration Asana Slack GitHub